aspirin has been researched along with sulforaphane in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ohmori, S; Sato, J; Yanaka, A | 1 |
| Grandhi, BK; Prabhu, S; Sutaria, D; Thakkar, A; Wang, J | 2 |
| Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J | 1 |
| Aldalati, AM; AlTinawi, BM; Azouz, HJ; Ganguly, P; Juurlink, BH | 1 |
| Akcılar, R; Bayat, Z; Bayhan, Z; Duzgun, SA; Kocak, C; Kocak, FE; Simsek, H; Zeren, S | 1 |
| Chenreddy, S; Khamas, W; Prabhu, S; Thakkar, A; Thio, A; Wang, J | 1 |
| Yanaka, A | 1 |
| Dulak, J; Florczyk-Soluch, U; Frołow, M; Józkowicz, A; Kachamakova-Trojanowska, N; Klóska, D; Markiewicz, J; Niżankowski, R; Nowak, WN; Stępniewski, J; Taha, H; Walter, Z | 1 |
2 review(s) available for aspirin and sulforaphane
| Article | Year |
|---|---|
Hydroxybenzoic acid isomers and the cardiovascular system.
Topics: Aspirin; Benzyl Alcohols; Cardiovascular System; Diet; Gentisates; Glucosides; Humans; Hydroxybenzoates; Isothiocyanates; Oxidative Stress; Phytochemicals; Sulfoxides | 2014 |
Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Gastric Mucosa; Gastritis; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Indomethacin; Intestinal Mucosa; Isothiocyanates; Mice; Oxidative Stress; Sulfoxides | 2017 |
8 other study(ies) available for aspirin and sulforaphane
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Sulforaphane protects small intestinal mucosa from aspirin/NSAID-induced injury by enhancing host defense systems against oxidative stress and by inhibiting mucosal invasion of anaerobic enterobacteria.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Capillary Permeability; Cell Line; Disease Models, Animal; Enterobacteriaceae; Enterobacteriaceae Infections; Intestinal Mucosa; Intestine, Small; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Rats; Sulfoxides; Thiocyanates; Up-Regulation | 2013 |
Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Cell Survival; Chemoprevention; Curcumin; Drug Combinations; Drug Stability; Drug Synergism; Humans; Inhibitory Concentration 50; Isothiocyanates; Lipids; Nanocapsules; Nanoconjugates; Pancreatic Neoplasms; Particle Size; Sulfoxides; Thiocyanates | 2012 |
The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspirin; Cell Line, Tumor; Cell Survival; Curcumin; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; MAP Kinase Signaling System; NF-kappa B; Pancreatic Neoplasms; Sulfoxides; Thiocyanates | 2013 |
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Carcinogens; Cell Line, Tumor; Cricetinae; Curcumin; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Lipids; Male; Mesocricetus; Nanoparticles; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Sulfoxides | 2013 |
Gastroprotective effects of sulforaphane and thymoquinone against acetylsalicylic acid-induced gastric ulcer in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Benzoquinones; Biomarkers; Gastric Mucosa; Gastrointestinal Agents; Immunohistochemistry; Isothiocyanates; Male; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Stomach Ulcer; Sulfoxides; Treatment Outcome | 2016 |
Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice.
Topics: Administration, Oral; Animals; Aspirin; Body Weight; Chitosan; Curcumin; Drug Liberation; Female; Isothiocyanates; Lipids; Mice, Inbred BALB C; Nanoparticles; Particle Size; Static Electricity; Sulfoxides; Toxicity Tests | 2016 |
Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity
Topics: AC133 Antigen; Antigens, CD34; Aspirin; Atorvastatin; Cells, Cultured; Culture Media, Conditioned; Hematopoietic Stem Cells; Heme Oxygenase-1; Humans; Immunoassay; Isothiocyanates; Leukocytes, Mononuclear; Metformin; Neovascularization, Physiologic; Phenotype; Resveratrol; Sulfoxides | 2019 |